1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). 1997. Guidance for industry: Extended release oral dosage forms: Development, evaluation, and application of in vitro/in vivo correlations.
2. European Medicines Agency. 2013. Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CPMP/EWP/280/96 Corr1) Draft XXIII.
3. Draft guideline on quality of oral modified release products,2012
4. Testing and correlation for oral controlled/modified‐release dosage forms;Skelly;Pharm Res,1990
5. In vitro/in vivo correlations: Scientific implications and standardisation;Cardot;Eur J Drug Metab Pharmacokinet,1993